Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
230.1 USD | -2.21% | +0.09% | -2.67% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.67% | 11.82B | |
+23.37% | 47.02B | |
+49.67% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
+30.23% | 12.34B | |
+20.99% | 11.8B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Stephens Adjusts Charles River Laboratories International's PT to $280 From $270, Keeps Overweight Rating